• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

5-氟尿嘧啶与改良卡诺伊溶液在降低牙源性角化囊肿复发率方面的有效性比较

Comparison of the effectiveness of 5-Fluorouracil and modified Carnoy's solution in reducing the recurrence of odontogenic keratocyst.

作者信息

Wanve Sandip A, Andrade Neelam N, Venkatakrishnan Lakshmi, Desai Harsh

机构信息

Nair Hospital Dental College, Mumbai, Maharashtra, India.

出版信息

J Oral Biol Craniofac Res. 2023 May-Jun;13(3):436-441. doi: 10.1016/j.jobcr.2023.03.007. Epub 2023 May 8.

DOI:10.1016/j.jobcr.2023.03.007
PMID:37207018
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10189504/
Abstract

INTRODUCTION

Odontogenic keratocysts (OKC) has a high potential for recurrence. Resection is currently the only fool-proof method to ensure that recurrence does not occur; however, it drastically affects the patient's function and aesthetics. Application of modified Carnoy's solution (MCS) as an adjunct to reduce the recurrence rate is currently in vogue. 5- Flurouracil (5-FU) is an anti-metabolite that has been used in the treatment of basal cell carcinoma and is relatively safer than MCS. The present study aims to compare the effectiveness of 5-UC and MCS in reducing the recurrence rate in OKC..

MATERIAL AND METHODS

A total of 42 OKCs were enucleated followed by application of MCS (control group, n = 21) or 5-FU dressing (study group, n = 21) following enucleation. Pain, swelling, temporary and permanent paresthesia paresthesia, bone sequestrum formation, osteomyelitis and recurrence in both groups were evaluated at periodic intervals up to 12 months post-surgery.

RESULTS

There was no significant difference in terms of pain, or swelling in both groups. Permanent paresthesia and recurrence rates were higher in patients treated with MC but the difference was not statistically significant.

CONCLUSION

5-FU is an easy-to-use, feasible, biocompatible and cost-effective alternative for MCS in the management of OKCs. Treatment with 5-FU, therefore, reduces the risk of recurrence and also the post-surgical morbidity associated with other treatment procedures.

摘要

引言

牙源性角化囊肿(OKC)具有较高的复发可能性。目前,切除是确保不复发的唯一可靠方法;然而,这会极大地影响患者的功能和美观。应用改良卡诺氏溶液(MCS)作为辅助手段以降低复发率目前很流行。5-氟尿嘧啶(5-FU)是一种抗代谢药物,已用于治疗基底细胞癌,且比MCS相对更安全。本研究旨在比较5-FU和MCS在降低OKC复发率方面的有效性。

材料与方法

共摘除42个OKC,摘除后对其中21例应用MCS(对照组),另外21例应用5-FU敷料(研究组)。在术后长达12个月的期间内定期评估两组的疼痛、肿胀、暂时性和永久性感觉异常、骨死骨形成、骨髓炎及复发情况。

结果

两组在疼痛或肿胀方面无显著差异。接受MCS治疗的患者永久性感觉异常和复发率较高,但差异无统计学意义。

结论

在OKC的治疗中,5-FU是一种易于使用、可行、生物相容性好且具有成本效益的替代MCS的方法。因此,5-FU治疗可降低复发风险以及与其他治疗程序相关的术后发病率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e06/10189504/2a98244d1276/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e06/10189504/d73cee3237c4/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e06/10189504/7af76c2e3226/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e06/10189504/81693c8fc875/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e06/10189504/d2bc02ed1b71/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e06/10189504/2a98244d1276/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e06/10189504/d73cee3237c4/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e06/10189504/7af76c2e3226/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e06/10189504/81693c8fc875/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e06/10189504/d2bc02ed1b71/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e06/10189504/2a98244d1276/gr4.jpg

相似文献

1
Comparison of the effectiveness of 5-Fluorouracil and modified Carnoy's solution in reducing the recurrence of odontogenic keratocyst.5-氟尿嘧啶与改良卡诺伊溶液在降低牙源性角化囊肿复发率方面的有效性比较
J Oral Biol Craniofac Res. 2023 May-Jun;13(3):436-441. doi: 10.1016/j.jobcr.2023.03.007. Epub 2023 May 8.
2
Is conservative treatment (enucleation using modified Carnoy's solution) of odontogenic keratocyst in the maxilla good prognosis?上颌骨牙源性角化囊肿采用保守治疗(使用改良卡诺伊溶液摘除)预后良好吗?
J Korean Assoc Oral Maxillofac Surg. 2023 Oct 31;49(5):287-291. doi: 10.5125/jkaoms.2023.49.5.287.
3
Comparing 5-Fluorouracil Versus Modified Carnoy's Solution for the Treatment of Odontogenic Keratocysts: A Systematic Review and Meta-Analysis.比较 5-氟尿嘧啶与改良 Carnoy 液治疗牙源性角化囊肿的疗效:系统评价和荟萃分析。
J Oral Maxillofac Surg. 2024 Nov;82(11):1433-1440. doi: 10.1016/j.joms.2024.06.181. Epub 2024 Jul 5.
4
Effectiveness of different treatments for odontogenic keratocyst: a network meta-analysis.不同治疗方法治疗牙源性角化囊肿的疗效:网络荟萃分析。
Int J Oral Maxillofac Surg. 2023 Jan;52(1):32-43. doi: 10.1016/j.ijom.2022.09.004. Epub 2022 Sep 21.
5
Peripheral ostectomy with the use of Carnoy's solution as a rational surgical approach to odontogenic keratocyst: a case report with a 5-year follow-up.使用卡诺氏液进行周边骨切除术作为治疗牙源性角化囊肿的合理手术方法:一例5年随访病例报告
Vojnosanit Pregl. 2012 Dec;69(12):1101-5.
6
How effective is 5-Fluorouracil as an adjuvant in the management of odontogenic keratocyst? A systematic review and meta-analysis.5-氟尿嘧啶作为牙源性角化囊肿辅助治疗的效果如何?系统评价和荟萃分析。
Br J Oral Maxillofac Surg. 2022 Jul;60(6):746-754. doi: 10.1016/j.bjoms.2022.02.001. Epub 2022 Feb 17.
7
5-Fluorouracil Is Associated With a Decreased Recurrence Risk in Odontogenic Keratocyst Management: A Retrospective Cohort Study.5-氟尿嘧啶治疗牙源性角化囊性瘤降低复发风险:一项回顾性队列研究。
J Oral Maxillofac Surg. 2021 Apr;79(4):814-821. doi: 10.1016/j.joms.2020.07.215. Epub 2020 Aug 5.
8
The Role of Adjunctive Chemical Solutions in the Treatment of Odontogenic Keratocysts: A Scoping Review.辅助化学溶液在牙源性角化囊肿治疗中的作用:一项范围综述
Cureus. 2023 Jul 13;15(7):e41822. doi: 10.7759/cureus.41822. eCollection 2023 Jul.
9
Modified Carnoy's Compared to Carnoy's Solution Is Equally Effective in Preventing Recurrence of Odontogenic Keratocysts.与 Carnoy 液相比,改良 Carnoy 液在预防牙源性角化囊肿复发方面同样有效。
J Oral Maxillofac Surg. 2021 Sep;79(9):1874-1881. doi: 10.1016/j.joms.2021.03.010. Epub 2021 Mar 24.
10
An evidence-based surgical algorithm for management of odontogenic keratocyst.基于证据的牙源性角化囊肿外科治疗算法。
Oral Maxillofac Surg. 2023 Jun;27(2):201-212. doi: 10.1007/s10006-022-01064-z. Epub 2022 Apr 27.

引用本文的文献

1
Efficacy of alternative agents to Carnoy's solution in the prevention of recurrence in odontogenic keratocyst: a systematic review and meta-analysis.用于预防牙源性角化囊肿复发的卡诺氏液替代剂的疗效:一项系统评价和荟萃分析
Evid Based Dent. 2025 Apr 23. doi: 10.1038/s41432-025-01138-3.

本文引用的文献

1
How effective is 5-Fluorouracil as an adjuvant in the management of odontogenic keratocyst? A systematic review and meta-analysis.5-氟尿嘧啶作为牙源性角化囊肿辅助治疗的效果如何?系统评价和荟萃分析。
Br J Oral Maxillofac Surg. 2022 Jul;60(6):746-754. doi: 10.1016/j.bjoms.2022.02.001. Epub 2022 Feb 17.
2
Cyst or Tumor? A systematic review and meta-analysis on the expression of p53 marker in Odontogenic Keratocysts.牙源性角化囊肿中 p53 标志物表达的系统评价和荟萃分析:囊肿还是肿瘤?
J Craniomaxillofac Surg. 2021 Dec;49(12):1101-1106. doi: 10.1016/j.jcms.2021.09.015. Epub 2021 Sep 28.
3
Modified Carnoy's Compared to Carnoy's Solution Is Equally Effective in Preventing Recurrence of Odontogenic Keratocysts.
与 Carnoy 液相比,改良 Carnoy 液在预防牙源性角化囊肿复发方面同样有效。
J Oral Maxillofac Surg. 2021 Sep;79(9):1874-1881. doi: 10.1016/j.joms.2021.03.010. Epub 2021 Mar 24.
4
Topical 5-fluorouracil application in management of odontogenic keratocysts.局部应用5-氟尿嘧啶治疗牙源性角化囊肿
J Oral Biol Craniofac Res. 2020 Oct-Dec;10(4):404-406. doi: 10.1016/j.jobcr.2020.07.008. Epub 2020 Jul 22.
5
Green synthesis and biological evaluation of novel 5-fluorouracil derivatives as potent anticancer agents.新型5-氟尿嘧啶衍生物作为有效抗癌剂的绿色合成及生物学评价
Saudi Pharm J. 2019 Dec;27(8):1164-1173. doi: 10.1016/j.jsps.2019.09.013. Epub 2019 Oct 31.
6
Recurrence of odontogenic keratocysts and possible prognostic factors: Review of 455 patients.牙源性角化囊肿的复发和可能的预后因素:455 例患者的回顾性研究。
Med Oral Patol Oral Cir Bucal. 2019 Jul 1;24(4):e491-e501. doi: 10.4317/medoral.22827.
7
Odontogenic keratocyst: imaging features of a benign lesion with an aggressive behaviour.牙源性角化囊肿:具有侵袭性行为的良性病变的影像学特征
Insights Imaging. 2018 Oct;9(5):883-897. doi: 10.1007/s13244-018-0644-z. Epub 2018 Jul 31.
8
Topical 5-Fluorouracil is a Novel Targeted Therapy for the Keratocystic Odontogenic Tumor.局部应用5-氟尿嘧啶是牙源性角化囊性瘤的一种新型靶向治疗方法。
J Oral Maxillofac Surg. 2017 Mar;75(3):514-524. doi: 10.1016/j.joms.2016.09.039. Epub 2016 Sep 30.
9
Histopathological features that predict the recurrence of odontogenic keratocysts.预测牙源性角化囊肿复发的组织病理学特征。
J Oral Pathol Med. 2012 May;41(5):408-14. doi: 10.1111/j.1600-0714.2011.01113.x. Epub 2011 Nov 16.
10
5% 5-Fluorouracil cream for treatment of verruca vulgaris in children.5%氟尿嘧啶乳膏治疗儿童寻常疣。
Pediatr Dermatol. 2009 May-Jun;26(3):279-85. doi: 10.1111/j.1525-1470.2008.00800.x.